New malaria vaccine shows promising resultsNovember 14th, 2007 - 2:26 am ICT by admin
It was also found that the vaccine reduced clinical illness due to malaria by 35 pct over a half-year period.
Though a large-scale Phase III study is essential to establish the efficacy of the vaccine, the results of the new study is encouraging.
The main objective of the study was to evaluate whether the vaccine should be cautiously administered for the age group more susceptible to malaria.
“We have shown for the first time that a vaccine can reduce the risk of malaria infection in young African infants exposed to intense P. falciparum transmission,” Lancet quoted CISM’s Pedro Alonso, MD, PhD, senior author of The Lancet article, principal investigator of the study, and head of the Barcelona Center for International Health Research (CRESIB) at the Hospital Clinic of the University of Barcelona, as saying,
“These tantalizing and unprecedented results further strengthen the vision that a vaccine may contribute to the reduction of the intolerable burden of disease and death caused by malaria,’ he added.
“We have invested over US$300 million in the development of this vaccine to make it as safe and effective as possible,” said Jean St
- Vaccine slashes malaria risk by half - Jan 14, 2011
- World's largest malaria vaccine trial begins in 7 African countries - Nov 04, 2009
- New strategy for developing 'next-generation' malaria vaccines - Nov 03, 2009
- Experimental malaria vaccine shows promising results - Dec 09, 2008
- Malaria vaccine in the offing - Nov 24, 2009
- Rotavirus vaccine could fight severe diarrhea in developing countries - Jan 28, 2010
- New malaria vaccine found safe for children - Feb 06, 2010
- Indian-origin scientist's malaria vaccine may eradicate the disease - Aug 16, 2009
- Scientists closer to developing anti-malaria shot - Aug 06, 2012
- New anti-malaria vaccine found effective in children - Feb 04, 2010
- Malaria vaccine could be available by 2011: report - Jun 01, 2009
- Edible vaccine for malaria on way - Dec 31, 2010
- Soon, an injectable vaccine to help kick the butt - Nov 18, 2009
- Swine flu jab under scrutiny over dangerous sleep disorder fears - Aug 28, 2010
- GlaxoSmithKline to go public with malaria data - Jan 20, 2010
Tags: 300, burden of disease, cism, clinical illness, half year, international health research, intolerable burden, lancet article, main objective, malaria infection, malaria vaccine, objective of the study, pct, pedro alonso, principal investigator, promising results, tolerability profile, university of barcelona, unprecedented results, vaccine efficacy